Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Pain Control for Radiotracer Injection in Breast Cancer
NCT04822597Phase 3Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Apr 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine 10% oropharyngeal spray in procedural pain, sponsored by University of Wisconsin–Madison. Started Apr 2021; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT04822597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04822597.